FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease - CNBC

FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease  CNBCUS FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease  ReutersWith expanded FDA nod for RSV shot Abrysvo, Pfizer gains edge on GSK's Arexvy. But will it amount to much?  FiercePharmaGSK's Arexvy Vaccine Shows Strong Efficacy Against RSV in Older Adults  AJMC.com Managed Markets Network